IL6 and neuromyelitis optica: Elevations in IL‐6 have previously been identified in several immune‐mediated neurologic diseases, most notably neuromyelitis optica spectrum disorder (NMOSD), resulting in novel therapeutic strategies highly effective in controlling the disease [10, 33].